About Neuland

WHO WE ARE

Established in 1984, Neuland Laboratories is a leading manufacturer of active pharmaceutical ingredients (APIs) and an end-to-end solutions provider for the pharmaceutical industry for chemistry-related services. Our expertise extends across generic API manufacturing, advanced intermediates as well as the development and commercialisation of API's for new chemical entities (NCEs). Supported by three world-class US FDA and EU GMP compliant manufacturing facilities and complex chemistry capabilities, Neuland has become a trusted partner for innovators as well as generics.

WHERE WE ARE BASED

We are headquartered in Hyderabad, India and our manufacturing and research facilities are situated near Hyderabad. Business development offices have been set up in the US, Europe and Japan to strengthen our global collaborations.

OUR MARKETS

We are a reliable manufacturing and development partner to customers in over 80 countries across US, Europe, Japan, APAC, India, MENA and LATAM.


  • US FDA refers to the United States Food and Drug Administration, a federal agency of the Department of Health and Human Services.
  • Good manufacturing practice (GMP) describes the minimum standard that a medicines manufacturer must meet in their production processes. The European Medicines Agency (EMA) coordinates inspections to verify compliance with these standards and plays a key role in harmonising GMP activities at European Union (EU) level.
  • cGMP refers to the Current Good Manufacturing Practice regulations enforced by the FDA.
OUR BUSINESS VERTICALS
Generic Drug Substance (APIs)

Our core business and operational expertise since inception has been the manufacturing of APIs. We have earned the identity of a preferred and reliable API supplier in the pharmaceutical industry primarily due to:

  • Consistency in product quality
  • Knowledge and ability to deal with niche chemistry
  • On-time delivery performance
Custom Manufacturing Solutions

Our deep understanding of complex chemical processes and manufacturing, derived from our proven expertise in chemical process development to manufacturing at varied scales, enables us to deliver Custom development and manufacturing solutions. Our offerings span the full range of the pharmaceutical industry’s chemistry requirements, from pre-IND through commercial manufacturing. We offer both small-scale clinical trial quantities and full commercial-scale supply with minimal technology transfer timelines. Our manufacturing facilities are compliant with cGMP requirements and meet environment and safety standards. The R&D facility is approved by the Department of Scientific and Industrial Research (DSIR), Government of India and inspected by the US FDA without any observations.

Peptide Capabilities

Our peptide synthesis services include production of peptides from milligrams to multi-kilogram scale by standard sequential chemical peptide synthesis and segment condensation strategies. Neuland has expertise in solution phase synthesis, solid phase synthesis and hybrid technology for complex peptides. We are currently a supplier of high-quality peptide building blocks like Pseudoproline dipeptides and other complex Fmoc building blocks.

OUR CORE VALUES
The Neuland Way

We follow a strong set of ethical values, termed ‘The Neuland Way’, which spurs integrity and motivation among the workforce. An internal cultural survey highlighted that Neuland is a strong, ethical, quality conscious and value-based Company that is committed to making a difference in people’s lives. The core of our business is built upon 5 values:

FAST FACTS

38+

years of experience

100+

APIs across 10 therapeutic areas

80+

countries served

907 kL

API manufacturing capacity

916+

DMFs filed worldwide

75%

revenue from exports

62

active US DMFs

1,521

Employees

REVENUE SEGMENTS
OUR GLOBAL REACH

% refers to FY 2022 sales by end market